Research on Human Insulin rDNA Safety and Efficacy in Patients With Type 2 Diabetes Mellitus

Clinical trial NCT05161741 · COMPLETED

Trial details

NCT number: NCT05161741
Sponsor: Getz Pharma
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Adverse Drug Event Effect of Drug Type 2 Diabetes Treated With Insulin

Start date: 2021-01-01
Primary completion: 2022-11-30
Enrollment: 238

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.